Your browser doesn't support javascript.
loading
Novel Role of Endothelial CD45 in Regulating Endothelial-to-Mesenchymal Transition in Atherosclerosis.
Peng, Qianman; Arulsamy, Kulandaisamy; Lu, Yao Wei; Wu, Hao; Zhu, Bo; Singh, Bandana; Cui, Kui; Wylie-Sears, Jill; Li, Kathryn; Wong, Scott; Cowan, Douglas B; Aikawa, Masanori; Wang, Da-Zhi; Bischoff, Joyce; Chen, Kaifu; Chen, Hong.
Afiliação
  • Peng Q; Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School; Boston, MA, 02115, USA.
  • Arulsamy K; Department of Cardiology, Boston Children's Hospital, Harvard Medical School; Boston, MA, USA.
  • Lu YW; Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School; Boston, MA, 02115, USA.
  • Wu H; Department of Cardiology, Boston Children's Hospital, Harvard Medical School; Boston, MA, USA.
  • Zhu B; Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School; Boston, MA, 02115, USA.
  • Singh B; Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School; Boston, MA, 02115, USA.
  • Cui K; Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School; Boston, MA, 02115, USA.
  • Wylie-Sears J; Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School; Boston, MA, 02115, USA.
  • Li K; Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School; Boston, MA, 02115, USA.
  • Wong S; Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School; Boston, MA, 02115, USA.
  • Cowan DB; Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School; Boston, MA, 02115, USA.
  • Aikawa M; Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School; Boston, MA, 02115, USA.
  • Wang DZ; Brigham and Women's Hospital, Harvard Medical School; Boston, MA, 02115, USA.
  • Bischoff J; Center for Regenerative Medicine and USF Health Heart Institute, Department of Internal Medicine, University of South Florida, Tampa.
  • Chen K; Vascular Biology Program, Boston Children's Hospital and Department of Surgery, Harvard Medical School; Boston, MA, 02115, USA.
  • Chen H; Department of Cardiology, Boston Children's Hospital, Harvard Medical School; Boston, MA, USA.
bioRxiv ; 2024 Sep 12.
Article em En | MEDLINE | ID: mdl-39282400
ABSTRACT

Background:

Protein-tyrosine-phosphatase CD45 is exclusively expressed in all nucleated cells of the hematopoietic system but is rarely expressed in endothelial cells. Interestingly, our recent study indicated that activation of the endogenous CD45 promoter in human endothelial colony forming cells (ECFCs) induced expression of multiple EndoMT marker genes. However, the detailed molecular mechanisms underlying CD45 that drive EndoMT and the therapeutic potential of manipulation of CD45 expression in atherosclerosis are entirely unknown.

Method:

We generated a tamoxifen-inducible EC-specific CD45 deficient mouse strain (EC-iCD45KO) in an ApoE-deficient (ApoE-/-) background and fed with a Western diet (C57BL/6) for atherosclerosis and molecular analyses. We isolated and enriched mouse aortic endothelial cells with CD31 beads to perform single-cell RNA sequencing. Biomedical, cellular, and molecular approaches were utilized to investigate the role of endothelial CD45-specific deletion in the prevention of EndoMT in ApoE-/- model of atherosclerosis.

Results:

Single-cell RNA sequencing revealed that loss of endothelial CD45 inhibits EndoMT marker expression and transforming growth factor-ß signaling in atherosclerotic mice. which is associated with the reductions of lesions in the ApoE-/- mouse model. Mechanistically, the loss of endothelial cell CD45 results in increased KLF2 expression, which inhibits transforming growth factor-ß signaling and EndoMT. Consistently, endothelial CD45 deficient mice showed reduced lesion development, plaque macrophages, and expression of cell adhesion molecules when compared to ApoE-/- controls.

Conclusions:

These findings demonstrate that the loss of endothelial CD45 protects against EndoMT-driven atherosclerosis, promoting KLF2 expression while inhibiting TGFß signaling and EndoMT markers. Thus, targeting endothelial CD45 may be a novel therapeutic strategy for EndoMT and atherosclerosis.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article